Categories
- Active Surveillance
- Announcements
- Ask Dr. Barken
- Biomarker
- Biopsy
- Bone Metastases
- Brachytherapy
- Cancer Stem Cells
- Castration Resistant Prostate Cancer
- CETC
- Checklist
- Choline 11 PET Scan
- Clinical Trials
- Coaching
- Color Doppler Trans-Rectal Ultrasound
- Cryo Immunotherapy
- Cryoablation
- CTC
- Decision Making
- Diagnosis
- Exosome
- Ferumoxytol
- Focal Therapy
- Genome
- HIFU
- High Intensity Foucused Ultrasound
- Hormonal Blockade
- Hormone Refractory Disease
- Imaging
- Immune Therapy
- Intermittent Hormonal Blockade
- Journal Club
- Laser
- LIfe Style
- Liquid Biopsy
- Lymph Nodes
- Markers
- Metastatic Disease
- Metastatic Prostate Cancer Disease
- MRI
- MRI Guided Focal
- Multi Parameteric MRI
- Nutrition
- PCREF Support Group Meeting
- PET scans
- Photodynamic Therapy
- Prevention
- Prognosis
- Prostate Cancer
- PSA
- Radiation Therapy
- Radiation treatment
- Radical Prostatectomy
- Sequential Hormonal Blockade
- Sexual Dysfunction
- Support for Prosatate Cancer
- Survival prostate cancer
- Testosterone
- Theranostics
- Treatments for Prostate Cancer
- Tumor Spheres
- Uncategorized
- Vaccine
Category Archives: Active Surveillance
Active Surveillance In Intermediate-Risk Prostate Cancer
Active Surveillance In Intermediate-Risk Prostate Cancer Called Into Question. https://youtu.be/dBk3z2T9KwQ Dr. Israel Barken brings info about higher risk of cancer specific mortality in the intermediate prostate cancer risk group. The study presentor at the GenitoUrinary Symposium 2015 was Dr. Andrew … Continue reading
Prostvac Vaccination for Localized Prostate Cancer Disease
Prostvac in Preventing Disease Progression in Patients with Localized Cancer Undergoing Active Surveillance. What is unique about this vaccine study , is the fact that it is given to patients with localized disease. Practically, the patient gets a series of vaccination … Continue reading
Prostate Cancer Convention 2014
Dr. Israel Barken, the medical director of the prostate cancer research and education foundation is interviewing Dr. Mark Scholz from the Prostate Cancer Research Institute about this year Prostate Cancer Convention.
Posted in Active Surveillance, Hormonal Blockade, Treatments for Prostate Cancer
Tagged Enzalutamide, Xtandi
2 Comments
Active Surveillance- Canadian Experience Part 2.
Active Surveillance: Current status and future direction. Part 2. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday. Click here to send me a question by sending a video. Click to view instructions.
Active Surveillance- Canadian Experience
Active Surveillance: Current status and future direction. Part 1. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday. Click here to send me a question by sending a video. Click to view instructions.
Posted in Active Surveillance, Biomarker, Imaging, MRI, Multi Parameteric MRI
Leave a comment
Active Surveillance: Contemporary Recommendation
Article written by Peter C. Albertsen, M.D., AUA News April 2014
Posted in Active Surveillance, Treatments for Prostate Cancer
Tagged Peter Albertsen M.D.
Leave a comment